International Clinical Trial: Ultrasensitive Digital PCR Detection of Maternal MCF-DNA Based on CRISPR/Cas12a for Predicting Early-Onset Neonatal Sepsis

Geneva, May 4 -- International Clinical Trials Registry received information related to the study (ChiCTR2600123177) titled 'Ultrasensitive Digital PCR Detection of Maternal MCF-DNA Based on CRISPR/Cas12a for Predicting Early-Onset Neonatal Sepsis' on April 22.

Study Type: Observational study

Study Design: Cohort study

Primary Sponsor: Chongqing Health Center for Women and Children

Condition: Neonatal sepsis

Intervention: EOS group:None

Recruitment Status: Not Recruiting

Phase: N/A

Date of First Enrollment: 2026-04-23

Target Sample Size: EOS group:100;Control group:200;

Countries of Recruitment: China

To know more, visit https://www.chictr.org.cn/showproj.html?proj=315547

Published by HT Digital Content Services with pe...